Interim Results of a Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient (dMMR) Cancers Resistant to Prior PD-(L)1 Inhibition
Nivolumab;Relatlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim Results of a Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient (dMMR) Cancers Resistant to Prior PD-(L)1 Inhibition ### Output: Nivolumab;Relatlimab